New Jersey 2022-2023 Regular Session

New Jersey Senate Bill S3422

Introduced
12/19/22  

Caption

Establishes central registry for sickle cell trait diagnoses; provides for informational outreach and genetic counseling.

Impact

By mandating the establishment of a registry, S3422 seeks to improve health outcomes for individuals with sickle cell trait through better-informed parental guidance and support. The bill requires follow-up notifications at critical stages in the child’s growth, emphasizing the necessity for continued medical consultations as the child enters adolescence. This proactive approach aims to educate families about the implications of the trait, assist in the management of related health risks, and promote awareness about the reproductive implications associated with carrying the trait.

Summary

Senate Bill S3422 aims to establish a central registry for newborn patients diagnosed with sickle cell trait within New Jersey, mandating that the Commissioner of Health create an effective notification and support system for families. The bill stipulates that when a newborn screening identifies sickle cell trait, the screening laboratory must inform the physician responsible for the care of the newborn, who will then document this information in the central registry. Subsequently, the parents will receive information regarding the benefits of genetic counseling, highlighting the importance of understanding potential health implications related to sickle cell trait for not only their current child but potential future offspring as well.

Contention

While the bill has garnered support for its potential public health benefits, it raises points of contention regarding confidentiality and the handling of sensitive medical information. By creating a public health registry that involves tracking genetic information, concerns are raised about privacy and the potential misuse of personal health data. Additionally, the criminalization of unlawful disclosure highlights the seriousness of maintaining confidentiality, yet it also underscores the challenges faced in balancing public health interests against individual rights to privacy.

Companion Bills

NJ A1988

Same As Establishes central registry for sickle cell trait diagnoses; provides for informational outreach and genetic counseling.

Previously Filed As

NJ S2516

Establishes central registry for sickle cell trait diagnoses; provides for informational outreach and genetic counseling.

NJ A1988

Establishes central registry for sickle cell trait diagnoses; provides for informational outreach and genetic counseling.

NJ A1809

Establishes central registry for sickle cell trait diagnoses; provides for informational outreach and genetic counseling.

NJ S2640

To improve sickle cell care

NJ S788

To improve sickle cell care

NJ H1347

To improve sickle cell care

NJ S678

To improve sickle cell care

NJ H1346

To improve sickle cell care

NJ H1161

To improve sickle cell care

NJ H7085

Sickle Cell Disease

Similar Bills

NJ A1809

Establishes central registry for sickle cell trait diagnoses; provides for informational outreach and genetic counseling.

NJ S2516

Establishes central registry for sickle cell trait diagnoses; provides for informational outreach and genetic counseling.

NJ A1988

Establishes central registry for sickle cell trait diagnoses; provides for informational outreach and genetic counseling.

NJ A1991

Clarifies statutory exemptions from mandatory immunization requirements for child care center and school attendance.

NJ A1812

Clarifies statutory exemptions from mandatory immunization requirements for child care center and school attendance.

NJ S4099

Prohibits reporting medical information of children without consent of parent or legal guardian.

NJ S887

Prohibits reporting medical information of children without consent of parent or legal guardian.

CT SB00457

An Act Concerning Clinical Medical Assistants.